Our results in MEFs predict that Alkbh8-/- mice will have an increased sensitivity to ROS inducing agents and may be predisposed to develop diseases linked to aberrant ROS production (i. e., neurodegenerative and inflammatory diseases or cancer) (Fig 7). Here, ALKBH8 is linked to cancer.